While the RAS isoforms NRAS and KRAS are uncommonly mutated and therefore not much recognized as oncogenic targets in HCC [19], HRAS alterations were found in murine hepatoblastomas and adjacent HCC [20]. This evidence concerns the gene HRAS and hepatocellular carcinoma.